ChengDa Pharmaceuticals Co. Ltd. (301201) — Cash Flow Reinvestment Rate
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Cash Flow Reinvestment Rate of 11.85x as of December 2025, reinvesting CN¥403.22 Million (capex CN¥69.02 Million plus investments CN¥334.20 Million) from operating cash flow of CN¥34.02 Million. See how much free cash does ChengDa Pharmaceuticals Co. Ltd. generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ChengDa Pharmaceuticals Co. Ltd. Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for ChengDa Pharmaceuticals Co. Ltd. across 7 annual periods. For the full cash flow conversion analysis, see 301201 cash flow metrics.
Annual Cash Flow Reinvestment Rate for ChengDa Pharmaceuticals Co. Ltd. (2019–2025)
Year-by-year capital reinvestment analysis for ChengDa Pharmaceuticals Co. Ltd.. See 301201 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 11.85x | CN¥403.22 Million | CN¥34.02 Million | CN¥69.02 Million | ▼ -72.0% |
| 2024 | 42.29x | CN¥1.21 Billion | CN¥28.65 Million | CN¥286.36 Million | ▲ +678.6% |
| 2023 | 5.43x | CN¥1.04 Billion | CN¥192.07 Million | CN¥224.67 Million | ▼ -78.3% |
| 2022 | 25.06x | CN¥1.19 Billion | CN¥47.67 Million | CN¥205.69 Million | ▲ +651.3% |
| 2021 | 3.34x | CN¥277.28 Million | CN¥83.14 Million | CN¥138.70 Million | ▲ +481.4% |
| 2020 | 0.57x | CN¥73.99 Million | CN¥128.97 Million | CN¥63.81 Million | ▼ -60.8% |
| 2019 | 1.46x | CN¥98.73 Million | CN¥67.52 Million | CN¥51.06 Million | — |